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Abstract
Myocardin belongs to the SAP domain family of transcription factors and is expressed specifically
in cardiac and smooth muscle during embryogenesis and in adulthood. Myocardin functions as a
transcriptional coactivator of SRF and is sufficient and necessary for smooth muscle gene expression.
However, the in vivo function of myocardin during cardiogenesis is not completely understood. Here
we clone myocardin from chick embryonic hearts and show that myocardin protein sequences are
highly conserved cross species. Detailed studies of chick myocardin expression reveal that myocardin
is expressed in cardiac and smooth muscle lineage during early embryogenesis, similar to that found
in mouse. Interestingly, the expression of myocardin in the heart was found enriched in the outflow
tract and the sinoatrial segments shortly after the formation of linear heart tube. Such expression
pattern is also maintained in later developing embryos, suggesting that myocardin may play a unique
role in the formation of those cardiac modules. Similar to its mouse counterpart, chick myocardin is
able to activate cardiac and smooth muscle promoter reporter genes and induce smooth muscle gene
expression in nonmuscle cells. Ectopic overexpression of myocardin enlarged the embryonic chick
heart. Conversely, repression of the endogenous chick myocardin using antisense oligonucleotides
or a dominant negative mutant form of myocardin inhibited cardiogenesis. Together, our data place
myocardin as one of the earliest cardiac marker genes for cardiogenesis and support the idea that
myocardin plays an essential role in cardiac gene expression and cardiogenesis.
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The heart is the first organ to form during mammalian development (Srivastava and Olson,
2000; Olson, 2002). Several transcription factors have been implicated in activation of cardiac
muscle gene expression during cardiomyocyte differentiation (Olson, 2004). NKX2.5, a
homeobox protein, is expressed specifically in the heart and has been shown to bind a regulatory
element in several cardiac gene control regions (Komuro and Izumo, 1993; Lints et al., 1993;
Lyons et al., 1995; Tanaka et al., 1999). MEF2C, a member of myocyte enhance factor-2
(MEF2) family of MADS-box transcription factors, binds to a conserved A/T-rich DNA
sequence in the control regions of the majority of cardiac, skeletal, and smooth muscle genes
and is essential for cardiogenesis (Lin et al., 1997; Black and Olson, 1998; McKinsey et al.,
2002). GATA4, a GATA family zinc finger protein which directly binds to the DNA sequence
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element (A/T)GATA(A/G), is expressed in the cardiac lineage throughout embryonic
development and in adulthood, and is required for early heart formation (Arceci et al., 1993;
Kelley et al., 1993; Ip et al., 1994; Kuo et al., 1997; Molkentin et al., 1997). Tbx1, Tbx5, and
Tbx20, members of the T-box transcription factors, have also been shown as important
regulators for cardiac gene expression and heart development (Horb and Thomsen, 1999;
Bruneau et al., 2001; Hiroi et al., 2001; Merscher et al., 2001; Brown et al., 2003, 2005; Bussen
et al., 2004; Hu et al., 2004; Singh et al., 2005; Stennard et al., 2005; Takeuchi et al., 2005).
Mutations in some of those key transcription factors have been linked to human cardiovascular-
related disease (Basson et al., 1997; Li et al., 1997; Epstein, 2001; Baldini, 2002).
We have recently identified a family of SAP domain transcription factors, myocardin and
myocardin-related transcription factors (MRTFs) (Wang et al., 2001, 2002; Wang and Olson,
2004). Unlike other cardiac transcription factors, which bind to the conserved DNA sequences
on the regulatory regions of their target gene, myocardin does not bind DNA alone, but forms
a stable ternary complex with serum response factor (SRF) bound to the DNA consensus
sequence CC(A/T)6GG, known as a CArG box. This interaction brings the powerful
transcription activation domain (TAD) of myocardin to SRF-dependent target genes with
resulting transcriptional activation (Wang and Olson, 2004; Wang et al., 2004b). Target genes
that can be significantly transactivated by myocardin include cardiac-specific gene atrial
natriuretic factor (ANF) and smooth muscle-specific gene SM22, both known targets for SRF
(Pipes et al., 2006). In addition, myocardin is a key component of a molecular switch that
regulates the ability of SRF to mediate cellular proliferation and muscle cell differentiation
(Wang et al., 2004b; Liu et al., 2005).
As a transcriptional cofactor of SRF, myocardin potently transactivates CArG box-containing
reporter genes (Wang et al., 2001). The functions of myocardin in smooth muscle gene
expression and vascular smooth muscle cell development have been well documented (Chen
et al., 2002; Du et al., 2003; Wang et al., 2003). Studies of myocardin knockout mice showed
embryonic lethality without the formation of vascular smooth muscle cells (Li et al., 2003).
However, the involvement of myocardin in cardiac development remains elusive. In
Xenopus, whereas a dominant negative mutant of myocardin interfered cardiogenesis,
overexpression of myocardin was able to ectopically induce cardiac gene expression (Wang
et al., 2001; Small et al., 2005). Surprisingly, the heart in myocardin knockout mouse embryos
seems to develop normally with an apparent normal expression of cardiac marker genes (Li et
al., 2003).
To further clarify the potential role of myocardin in cardiogenesis, we cloned the avian ortholog
of mammalian myocardin. Here we show that chick myocardin is specifically expressed in the
cardiac lineage during early embryogenesis, similar to that found in mouse. Interestingly, we
found that myocardin expression in the developing heart is not evenly distributed, instead, the
highest myocardin expression is detected in the outflow tract and the sinoatrial segments. Like
its mammalian counterpart, the chick myocardin is able to potently activate cardiac and smooth
muscle gene expression as well as induce smooth muscle gene expression in nonmuscle cells.
Whereas ectopic overexpression of myocardin seems to promote cardiac differentiation,
repression of myocardin activity dramatically inhibits cardiogenesis in chick embryos. Our
data establish myocardin as an early cardiac marker and support the view that myocardin plays
an essential role in cardiogenesis.
MATERIALS AND METHODS
Cloning of Chick Myocardin
We used the mouse myocardin protein sequence to search the NCBI database (EST) and found
one chick EST clone of 669 bp (GenBank access # BU143596) with high homology. Using
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this chick cDNA as a probe to screen a Hamburg-Hamilton (HH) Stage 21 embryonic chick
heart cDNA library (a generous gift of Dr. Jim Lin, University of Iowa), we identified several
overlapped cDNA clones from 500 bp to 1.5 kb. Sequencing of those cDNAs confirmed that
they are partial sequences of the deduced chick myocardin gene. Using the most 5′-sequence
of these cDNAs as a probe to rescreen, the cDNA library did not yield any additional upstream
sequence information. To clone the full-length chick myocardin sequence, we used the mouse
myocardin protein sequence to blast the chick genomic sequence database and found the
putative chick myocardin genomic sequence on chromosome 18. This information allows us
to deduce a chick myocardin full-length cDNA sequence. Based on the above information, we
designed PCR primers which span over the putative chick myocardin open reading frame
(ORF) sequence. Multiple cDNA fragments were PCR-amplified from cDNA pools derived
from HH Stage 25 chick embryonic hearts and gizzard. Multiple cDNA fragments were
amplified and subcloned into a pcDNA expression vector with a N-terminal Myc tag. All the
cDNA clones were confirmed by sequencing.
Whole Mount In Situ Hybridization
Whole mount in situ hybridization was essentially performed as described previously (Wang
et al., 1999) with minor modification. Two different cDNA fragments, which cover distinct
portions of the chick myocardin transcripts (ORF and 3′ UTR), were used as templates for in
vitro transcription to make antisense DIG-labeled riboprobes. These two probes were used to
hybridize with staged chick embryos and yielded similar results. A sense-oriented riboprobe
was used as a negative control. All experiments were repeated at least twice and multiple
embryos were used for each developmental stage.
Cell Culture and Transfection Assays
Transfection of COS and 10T1/2 cells and luciferase reporter assays were performed as
described (Wang et al., 2001, 2003, 2004b). Unless otherwise indicated, 100 ng of reporter
plasmid and 100 ng of each activator plasmid were used. The total amount of DNA per well
was kept constant by adding the corresponding amount of expression vector without a cDNA
insert. All the transfection experiments were repeated at least twice in duplication. CMV-lacZ
was included as an internal control for variations in transfection efficiency.
The mouse myocardin expression plasmids have been described (Wang et al., 2001, 2003,
2004b). Unless otherwise indicated, full-length chick and mouse myocardin expression
plasmids were used. For chick myocardin expression constructs, varieties of chick myocardin
cDNA fragments amplified from embryonic heart and gizzard cDNA pools were cloned into
the pcDNA3.1 expression vector with a N-terminal Myc tag. To determine whether the
constructs encode for myocardin proteins with correct size, the expression plasmids were
transfected into the COS cells and the protein expression was confirmed by Western blot
analysis. Myocardin deletion mutants were generated through PCR-based mutagenesis using
the QuickChange kit (Stratagen). All mutations were confirmed by DNA sequencing. The
SM22-luciferase reporter contained the 1,434 bp promoter and the ANF-luciferase reporter
contained the 638 bp promoter (Wang et al., 2001).
Immunohistochemistry and Whole Mount Immunostaining of Chick Embryos
Myogenic conversion assays in 10T1/2 cells were performed as described (Wang et al.,
2003) except that Lipofectamine reagent (Invitrogen) was used for transfection. After
transfection, 10T1/2 cells were shifted to differentiation medium (DMEM plus 2% horse
serum) for 48 hr before analysis. Mouse anti-SM-α-actin monoclonal antibody (1A4, Sigma)
was used to monitor smooth muscle gene induction.
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Whole mount immunostaining of chick embryos was performed primarily according to (Corson
et al., 2003) with some modifications. After incubation with primary antibody (MF20, 1:5,
Developmental Study Hybridoma Bank, Department of Biological Sciences, University of
Iowa), an alkaline phosphatase (AP)-coupled secondary antibody was applied and color
reaction was developed using the BM-Purple substrate (Roche).
Antisense Treatment and Microelectroporation
Antisense treatment and expression vector microelectroporation were performed as described
previously (Wang et al., 2004a). Briefly, fertilized chick eggs (CBT Farm, Chestertown, MD)
were incubated to approximately HH Stage 5–6. The embryos were explanted in new cultures
and subjected to antisense treatment or microelectroporation. Antisense oligonucleotides were
designed using IDT SciTools and synthesized as phosphorothioate derivatives and purified by
HPLC (IDT, Corralville, IA). The sequence for the 20 bp antisense oligonucleotide that targets
the C-terminus of the chick myocardin is 5′-ACTCCTCTCCTCCCATCTTC-3′. The inverse
of the above sequence was used as control. Staged chick embryos were treated with 10 μL
oligonucleotide mixed with lipofectamin (Invitrogen) at the concentration of 40 μM. For
microelectroporation, a gold-plated cathode was fixed in the bottom of a 60-mm dish with a
thin layer of Ringer’s saline, and Stage 6 embryos were prepared for new culture and put onto
the cathode. About 1 μg of expression plasmid myocardin or dominant negative myocardin
mixed with pMES, or pMES alone as control, was injected into the target site between the
blastoderm and vitelline membrane using a glass capillary. A platinum anode (0.5 mm in
diameter) was then placed on the hypoblast at the prospective heart-forming region. The
parameters for electroporation were 5 pulses of 5 V for the duration of 25 msec with the
intervals of 454 msec. The treated embryos were placed on the agar media in new cultures and
incubated in 38°C to the desired stages for immunostaining for gene expression. The expression
of expression plasmids after microelectroporation was monitored by GFP expression of pMES
plasmid.
RESULTS
Cloning of Avian Myocardin
A partial chick myocardin cDNA sequence was identified when the mouse myocardin protein
sequence was used to search the NCBI EST database. Using this chick myocardin cDNA as a
probe to screen a chick embryonic heart cDNA library, we identified additional overlapped
cDNA clones, representing chick myocardin sequences. Finally, a PCR-based cloning
approach allowed us to clone the chick myocardin cDNA sequences (see Material and
Methods). Among these cDNA clones, two appear to represent the full-length chick myocardin
cDNA with a deduced peptide of 909 amino acids (Fig. 1).
In addition to the putative full-length chick myocardin cDNAs, we have also cloned several
short isoforms of the chick myocardin gene, with the size ranged from 1.1 to 2.2 kb. The
deduced amino acid sequences of these isoforms were aligned to the full-length protein (Fig.
1). Interestingly, most of those isoforms contain an intact C-terminal transactivation domain
(TAD). Analysis against chick genomic sequences indicates that all of these short transcripts
are the products of differential splicing from the same chick myocardin gene (data not shown).
Using the chick myocardin protein sequence to blast the chick genomic database at decreased
stringency, we found three hits on chick genomic loci on chromosomes 18, 14, and 1,
respectively (data not shown). Given that we have previously identified three myocardin family
proteins from mammals, myocardin, MRTF-A, and MRTF-B (Wang et al., 2002), those three
chick genes are likely the avian homologues of myocardin family transcription factors.
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Myocardin Protein Sequences Are Highly Conserved
Comparison of myocardin protein sequences cross species shows that the chick myocardin
protein shares 64%, 64%, and 67% amino acid sequence identity to its frog, mouse, and human
counterparts, respectively (Fig. 1B). The chick myocardin protein contains the predicted
conserved domains found in other members of the myocardin family proteins. Those include
the N-terminal RPEL domain (RPEL), the basic domain, glutamine-rich domain (Q-domain),
SAP domain, leucine-zipper like domain (LZ), and the C-terminal transactivation domain
(TAD) (Fig. 1). Aligning the chick myocardin cDNA sequence against the chick genomic
sequences revealed that the chick myocardin has a very similar exon-intron structure as that
of mouse myocardin gene (data not shown). Together, these data demonstrate that the
myocardin proteins are highly conserved evolutionally.
Expression of Chick Myocardin During Embryogenesis
We and others have previously reported that myocardin is specifically expressed in cardiac
and smooth muscle cells during mouse development and in adulthood (Wang et al., 2001; Chen
et al., 2002; Du et al., 2003; Ueyama et al., 2003). Most of those previous experiments were
performed using in situ hybridization on mouse embryo tissue sections. Unfortunately, such
approach was not an ideal approach to view the three-dimensional spatiotemporal expression
pattern of myocardin. We have recently shown, using whole mount in situ hybridization, that
Xenopus myocardin is expressed in the heart of frog embryos (Small et al., 2005). However,
this study was limited to only very early developmental stages and Xenopus myocardin
expression was not studied in whole mount frog embryos at later developmental stages (Wang
et al., 2001; Small et al., 2005). We therefore decided to apply whole mount in situ hybridization
to examine the expression patterns of the chick myocardin during embryogenesis. Two
independent antisense riboprobes, which are from two different region of the chick myocardin
cDNA, were used in the whole mount in situ hybridization and both yielded the same
experimental results. Sense oriented probes served as negative controls and no signal was
detected in those embryos (data not shown). The chick myocardin transcripts are first clearly
detected in the cardiac crescent, the precursor of earliest cardiac lineage, of HH Stage 8–9 chick
embryos (Fig. 2A). Myocardin expression was not detected in any other region of the embryos
at this stage (Fig. 2A). At HH Stage 10, myocardin is expressed in the newly formed linear
heart tube with an apparently homogenous expression level in the whole heart tube (Fig. 2B).
Myocardin continues to be expressed in the looping heart of HH Stage 11 embryos.
Interestingly, stronger myocardin expression is detected at the posterior portion of the
developing embryonic heart, the future atrium and the sinus venosus (Fig. 2C,D). By HH Stage
12–13, myocardin expression is still restricted to the developing heart, but a much higher
expression level of myocardin transcript is detected in the outflow tract and future atria (Fig.
2E–H). Cardiac-specific expression of myocardin continues in HH Stage 15 chick embryos,
with higher expression in the outflow tract and atria (Fig. 2I–L, arrows). Similar myocardin
expression pattern is maintained in HH Stage 18 chick embryos (Fig. 2M–P). At HH Stage 21,
myocardin expression is detected in the heart where a high level of expression in the ventricle
is evident (Fig. 2Q–T). Of a particular note, myocardin is also expressed in the developing
allantoic vesicle, a smooth muscle enriched structure (Fig. 2Q). The expression patterns of
chick myocardin in developing chick embryos are specific: we were able to obtain identical
expression patterns from multiple independent experiments using multiple embryos. Together,
these data establish cardiac-specific expression of the chick myocardin during development.
To compare the observed chick myocardin expression patterns with that of its mouse
counterpart, we performed whole mount in situ hybridizations using a mouse myocardin
riboprobe on embryonic day 9.5 mouse embryos (E9.5). The mouse myocardin expression
pattern is very similar to that of the chick myocardin (Fig. 3). The highest expression was
detected in the outflow tract and atrium. Intriguingly, we have consistently observed that the
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expression of the mouse myocardin in a restricted region of the forebrain of the staged mouse
embryos (Fig. 3B). These results are particularly interesting, given a recent report showing that
SRF and myocardin are involved in smooth muscle gene expression and cerebral blood flow
of Alzhemer’s patients (Chow et al., 2007).
Activation of Cardiac and Smooth Muscle Reporter Genes by Chick Myocardin
We have previously demonstrated that the mouse myocardin was able to potently activate
cardiac and smooth muscle target gene expression (Wang et al., 2001). The high conservation
between the mouse and chick myocardin protein sequences as well as the similarity in their
expression patterns during embryogenesis suggest that the chick myocardin may function in a
similar fashion. We therefore tested if the chick myocardin is able to activate cardiac reporter
gene ANF and smooth muscle reporter gene SM22, using transfection luciferase reporter assays
in cultured mammalian cells. Expression plasmids for full-length chick myocardin potently
activate both the ANF and SM22 luciferase reporters to a level comparable to that of the mouse
myocardin (Fig. 4A,B). However, the chick myocardin short isoforms were not able to activate
those reporter genes (Fig. 4A,B). Since most of these chick myocardin short isoforms lack the
N-terminal region of myocardin protein, which is highly evolutionary conserved, these data
suggest that the N-terminal portion of the myocardin protein is essential for its function. Those
data are consistent with our previous reports in which we showed that the specificity of the
mouse myocardin protein is determined by its N-terminus (Wang et al., 2001, 2004b; Wang
and Olson, 2004; Cao et al., 2005).
We then examined whether a dominant negative mutant of mouse myocardin, which lacks its
C-terminal TAD domain, was able to interfere with the transcriptional activity of the full-length
chick myocardin. The mouse myocardin dominant negative mutant dramatically repressed the
transcriptional activity of the chick myocardin, similar to its ability to repress the transcriptional
activity of the full-length mouse myocardin (Fig. 4C; and Wang, et al., 2001). Similarly, a
chick myocardin dominant negative mutant which lacks its TAD domain, potently suppressed
the transactivities of both mouse and chick myocardin proteins (Fig. 4C). These results
demonstrated that the chick myocardin is a potent transcription factor for cardiac and smooth
muscle genes.
Activation of Smooth Muscle Genes by Chick Myocardin
Next, we tested whether ectopic expression of the chick myocardin in nonmuscle 10T1/2 cells
could activate smooth muscle gene expression. Similar to what we have observed previously
for the mouse myocardin, smooth muscle gene expression is readily detected by
immunostaining using a monoclonal antibody against smooth muscle α-actin after chick
myocardin was transfected into the 10T1/2 cells (Fig. 5A). Semiquantitative RT-PCR analyses
demonstrate that the chick myocardin is able to induce smooth muscle gene expression to a
level comparable to that of the mouse myocardin when ectopically overexpressed in the 10T1/2
cells (Fig. 5B). Together, these data demonstrate that not only the protein structure and
expression pattern but also the function of myocardin proteins are highly conserved.
Myocardin Is Required for Cardiogenesis in Chick Embryos
To investigate the in vivo function of myocardin during cardiac development, we set out to
overexpress or knock down myocardin in cultured chick embryos. An expression plasmid for
either chick or mouse myocardin was introduced into HH Stage 5–6 chick embryos using
microelectroporation procedure (Wang et al., 2004a). An expression plasmid for GFP was
coelectroporated in order to monitor the uptake and expression of introduced DNA. Processed
embryos were cultured for additional 24 hr to reach HH Stage 10–11 before harvesting. Control
and treated embryos were then proceeded for whole mount immunohistology analysis using a
MF20 antibody, which specifically recognize cardiac and skeletal muscle myosin heavy chain
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(Fig. 6A,B; and Chen et al., 2006). Overexpression of myocardin in chick embryos caused an
enlargement of embryonic hearts (61%, n = 18) (Fig. 6D). In contrast, control embryos with
only a GFP expression plasmid did not show any change in their heart development (n = 15)
(Fig. 6C). We did not observe ectopic MF20-positive tissues in any other region of the chick
embryos other than the heart region. We did not obtain ectopic smooth muscle marker gene
expression in those embryos (data not shown).
Conversely, introduction of a dominant negative mutant of myocardin into the chick embryos
leads to a defect in cardiogenesis which is associated with the decrease or completed blockage
of cardiac marker gene MHC expression (Fig. 6G,H and data not shown). Such observed heart
development defects are specific because other aspects of embryonic development appear to
be normal in those embryos. To further confirm the above observation, we applied an antisense
oligonucleotide specific to the chick myocardin sequence to staged chick embryos in culture.
Antimyocardin antisense oligonucleotide dramatically inhibits cardiac development and
represses the expression of myosin heavy chain protein, as marked by MF-20 antibody staining.
As a negative control, no inhibitory effect was observed in cultured chick embryos treated with
a control oligonucleotide (Fig. 6E,F). Collectively, our data demonstrated that myocardin plays
an essential role in cardiogenesis in chick embryos.
DISCUSSION
In this study, we have cloned the avian ortholog of the mammalian myocardin gene. We show
that the chick myocardin is specifically expressed in the developing hearts of early chick
embryos. Interestingly, we found that the expression of the chick myocardin in the heart is
enriched in the outflow tract and atrium during early embryogenesis, indicating that myocardin
may play a role in the morphogenesis of those modules. We have also demonstrated that chick
myocardin, like its mammalian counterparts, is able to potently activate cardiac and smooth
muscle gene expression. Most importantly, gain- and loss-of-function studies in chick embryos
clearly established an important role of the myocardin protein in cardiac gene expression and
heart development.
Expression of Myocardin During Heart Development
The transcripts of the chick myocardin are first detected in the cardiac crescent of chick
embryos, making myocardin one of the earliest markers for cardiogenic specification. Our
expression studies reveal that the expression of the chick myocardin is restricted to the cardiac
lineage during early embryogenesis, consistent with previous studies in other species, including
frog and mouse (Wang et al., 2001; Small et al., 2005). Unexpectedly, we found that the
expression of myocardin is not homogenously distributed in the whole heart. Instead, a much
higher level of myocardin expression was detected in the outflow tract and developing atria of
chick embryos. Such myocardin expression pattern suggests that myocardin may play a specific
role in the morphogenesis of outflow tract and atria.
Recently, the regulatory regions of the mouse myocardin gene which direct its cardiac- and
smooth muscle-specific expression during embryogenesis and in adult animals were identified
(Creemers et al., 2006a). It has been shown that the cardiac- and smooth muscle-specific
expression of the mouse myocardin gene is controlled by the combination of MEF2, Foxo, and
Tead transcription factors to bind to the myocardin enhancer. In particular, the MEF2 and Foxo
proteins are responsive to the expression of myocardin in both cardiac and smooth muscle
lineage, whereas the Tead transcription factors appear to be required for the expression of
myocardin in the smooth muscle cells (Creemers et al., 2006a). It will be important to determine
whether myocardin contributes to the developmental defects associated with the loss-of-
function of Mef2, Foxo, or Tead proteins.
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It is now recognized that two distinct sources of cardiac precursor cells, which come from the
so-called “primary” and “secondary heart fields,” are needed for the cardiogenesis (Kirby,
2002; Buckingham et al., 2005). Whereas the primary heart field is essential for the formation
of primary heart tube, additional cardiac precursor cells are recruited from the secondary heart
field to contribute to the future right ventricle and outflow tract (Kelly et al., 2001; Cai et al.,
2003). Loss-of-function studies in genes which are thought to play an important role in the
secondary heart field fate clearly demonstrated that the secondary heart field is required for
the morphogenesis of outflow tract and right ventricle (Srivastava et al., 1995, 1997; Lin et al.,
1997; Kelly et al., 2001; Waldo et al., 2001; Cai et al., 2003; von Both et al., 2004). In this
study, we found that the chick myocardin is expressed in the cardiac crescent of Stage 8 chick
embryos. Later on, its expression in the developing heart is enriched in the outflow tract and
atria. It will be extremely interesting to determine whether myocardin is also expressed in the
secondary heat field and if it plays a role in the morphogenesis of right ventricle and outflow
tract.
Function of Myocardin in Heart Development and Cardiac Gene Expression
Previously, we showed that myocardin plays a critical role during normal heart development,
when a dominant-negative myocardin mutant was introduced into Xenopus embryos to inhibit
the function of endogenous myocardin (Wang et al., 2001). Such conclusion was further
supported by a recent study where myocardin was knocked down by morpholino oligos in
Xenopus. Significantly, ectopic overexpression of myocardin in Xenopus was sufficient to
induce ectopic cardiac gene expression, suggesting that myocardin may function as a key
transcription factor to activate cardiac gene expression program (Small et al., 2005).
Surprisingly, the early cardiogenesis appears to be normal in the myocardin knockout mouse
embryos. This has been explained by the possible functional redundancy between the
myocardin family of transcription factors (MRTF-A and MRTF-B) (Li et al., 2003). In this
study, when the chick myocardin was introduced into early chick embryos, we observed an
increase in heart size. However, we never observed ectopic cardiac marker gene induction
outside the cardiac developmental region. It will be interesting to understand why evolution
has specified the myocardin’s role in controlling cardiac development in such a way that a
much more profound role is found in amphibians than in avians and mammals.
Myocardin Family of Transcription Factors and Their Function
In addition to myocardin, we have identified two MRTFs-A and -B from mouse, which share
homology with the SAP domain, as well as the basic and glutamine-rich domains of myocardin
(Wang et al., 2002). Myocardin and MRTFs comprise a novel family of SRF cofactors with
extraordinary transcriptional potency (Wang and Olson, 2004). Whereas myocardin is
expressed in a cardiac- and smooth muscle-specific manner, MRTF-A and MRTF-B are widely
expressed in embryonic and adult tissues (Wang et al., 2002). Their different expression
patterns and differential effects on SRF activity suggest that myocardin and MRTFs participate
in distinct SRF-dependent programs of gene expression. Indeed, gene targeting studies reveal
that MRTF-A is required for the differentiation of mammary myoepithelial cells (Li et al.,
2005, 2006; Oh et al., 2005; Sun et al., 2006; Wei et al., 2007) and MRTF-B is essential for
the correct patterning of branchial arch arteries and outflow tract (Li et al., 2005; Oh et al.,
2005; Wei et al., 2007). Using the chick myocardin protein sequence to search the chick genome
at decreased stringency, we found three genomic loci on chromosomes 18, 14, and 1,
respectively, suggesting the presence of three myocardin family members in chick (data not
shown). Surprisingly, when we used the chick or mouse myocardin protein sequences to search
the genomes of fugu fish and zebra-fish, we identified four genomic loci in those organisms,
suggesting the existence of one additional myocardin family member (Wang et al., unpublished
observation).
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Intriguingly, the mouse myocardin was found to interact with MEF2 proteins via a unique N-
terminal peptide sequence. We have found that such MEF2 interacting domain is highly
conserved in the chick myocardin. Furthermore, such unique MEF2-binding domain of mouse
myocardin was used to search for additional MEF2 interacting proteins and has lead to the
identification of MASTR, a novel SAP domain protein and coactivator of MEF2 proteins.
MASTR was shown to synergize with MEF2 to activate myogenic gene expression in skeletal
muscle (Creemers et al., 2006b). However, MASTR is unlikely a new member of myocardin
family transcription factor, even thought it is a member of SAP domain containing nuclear
proteins. MASTR does not contain the signature domains found in other myocardin family
members (Basic, Q-domain, Leucine Zipper). Clearly, the discovery of myocardin family of
transcription factors and related proteins has provided opportunity to investigate the molecular
mechanisms of cell growth and differentiation. With the cloning and characterization of the
chick myocardin, it will be important in the future to study the upstream signals and
downstream regulatory target genes which mediate the function of myocardin in muscle
differentiation and muscle gene expression.
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Cloning of the chick myocardin and the comparison of myocardin protein sequences from
chick, frog, mouse, and human. (A) Diagram of the chick myocardin isoforms cloned in this
study. Protein structural domains are indicated as follows: RPEL, RPEL domain; B, basic
domain; Q, glutamine-rich domain; SAP, SAP domain; LZ, leucine zipper-like domain; TAD,
transcription activation domain. (B) Alignment of myocardin protein sequences from chick
(cMyocd), frog (xMyocd), mouse (mMyocd), and human (hMyocd). Some of the important
domains are labeled. The chick myocardin is 64%, 64%, and 67% identical to its frog, mouse,
and human homologues, respectively.
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Expression of chick myocardin transcripts in chick embryos. Whole mount in situ hybridization
was used to detect the expression of chick myocardin transcripts in staged chick embryos during
early developmental stages. Myocardin expression was first detected in the cardiac crescent
(cc) of Hamburger-Hamilton (HH) Stage 9 chick embryos (A). Myocardin is expressed in the
newly formed heart tube (h) of HH Stage 10 and 11 embryos (B and C). Higher level of
myocardin expression was detected in the future atrium (a) of HH Stage 11 embryo (D).
Myocardin expression is restricted to the cardiac lineage in HH Stage 12–13 chick embryos
(E–H). Arrows indicate higher level of myocardin expression detected in the atrium (a) and
outflow tract (ot). Myocardin expression in the hearts of HH Stage 15 chick embryos (I–L).
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Arrows indicate higher level of myocardin expression in the atrium (a) and outflow tract (ot).
Myocardin expression in HH Stage 18 chick embryos (M–P). Arrows indicate higher level of
myocardin expression detected in the atrium (a) and outflow tract (ot). Myocardin is expressed
in the developing heart (h) and allantoic vesicle (all) of HH Stage 21 chick embryos (Q–T).
Images in 2D, J, L, N, P, R, and T represent higher magnification of 2C, I, K, M, O, Q, and S,
respectively. Abbreviations: a, atrium; all, allantoic vesicle; cc, cardiac crescent; h, heart; lv,
left ventricle; ot, outflow tract; rv, right ventricle; v, ventricle.
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Expression of mouse myocardin transcripts in mouse embryos. Whole mount in situ
hybridization was used to detect the expression of mouse myocardin transcripts in staged mouse
embryos. A–D: Mouse myocardin is expressed in the hearts of embryonic day 9.5 (E9.5) mouse
embryos with higher expression in the outflow tract and atrium (arrows). E–H: Mouse
myocardin expression in a restricted region of anterior asects of E10.5 (E and F) and E12.5 (G
and H) mouse embryos. Abbreviations: a, atrium; h, heart; v, ventricle.
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Activation of cardiac and smooth muscle reporter genes by myocardin proteins. COS cells
were transfected with ANF or SM22 luciferase reporters and the indicated chick or mouse
myocardin expression constructs. Luciferase activities were measured and results were
presented as fold-activation from three independent experiments in duplication. (A) Activation
of the ANF promoter luciferase reporter by chick myocardin (cMyo). Only the full-length
cMyo, but not the short isoforms, was able to activate ANF reporter. Mouse myocardin (mMyo)
was used for comparison is this assay. (B) Activation of the SM22 promoter luciferase reporter
by the full-length cMyo, not the short isoforms. (C) Dominant negative mutants of chick or
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mouse myocardin repress wild-type (full-length) myocardin-mediated transactivation of the
SM22 promoter luciferase reporter.
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Induction of smooth muscle gene expression by chick myocardin. A: 10T1/2 cells were
transfected with chick myocardin (cMyocardin) expression construct. Twenty-four hours after
transfection, the cells were shifted to differentiation medium (DMEM plus 2% horse serum)
for 48 hr and smooth muscle α-actin (sm-α-actin) expression was assayed by immunostaining.
Cells transfected with a pcDNA vector were used as a control (vector). B: 10T1/2 cells were
transfected with chick myocardin (cMyocardin) or mouse myocardin (mMyocardin)
expression construct. Twenty-four hours after transfection, the cells were shifted to
differentiation medium (DMEM plus 2% horse serum) for 48 hr. Total RNAs were isolated
and the expression of smooth muscle genes (SM-α-actin and SM22) were assayed using
semiquantitative RT-PCR. GAPDH was measured as a loading control.
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Myocardin is essential for cardiogenesis in chick embryos. A,B: Whole mount immunostaining
of HH Stage 12 chick embryos using the MF20 monoclonal antibody, which specifically
recognizes striated cardiac and skeletal muscle myosin heavy chain. The developing heart
(arrow) and somites (arrowhead) are indicated. B: Higher magnification of (A). Chick embryos
in new culture were microelectroporated with expression plasmids for either a wild-type
myocardin (D) or a dominant negative mutant form of myocardin (H), or treated with antisense
oligonucleotides specific for myocardin (F) or their respective controls (C, G, and E) as
described in Materials and Methods. After incubation for additional 24 hr, embryos were
harvested and analyzed by whole mount immunostaining using the MF-20 monoclonal
antibody, which marks the cardiac structure (blue).
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